The avian retroviruses reticuloendotheliosis virus strain A (REV-A) and spleen necrosis virus (SNV) are not naturally infectious in human cells. However, REV-A-derived viral vectors efficiently infect human cells when they are pseudotyped with envelope proteins displaying targeting ligands specific for human cell-surface receptors. Here we report that vectors containing the gag region of REV-A and pol of SNV can be pseudotyped with the envelope protein of vesicular stomatitis virus (VSV) and the glycoproteins of different rabies virus (RV) strains. Vectors pseudotyped with the envelope protein of the highly neurotropic RV strain CVS-N2c facilitated cell type-specific gene delivery into mouse and human neurons, but did not infect other human cell types. Moreover, when such vector particles were injected into the brain of newborn mice, only neuronal cells were infected in vivo. Cell-type-specific gene delivery into neurons may present quite specific gene therapy approaches for many degenerative diseases of the brain.
Introduction
Cell-type-specific gene delivery into neuronal cells will be one of the most important prerequisites for in vivo gene therapy of neurological disorders in humans (Costantini et al., 2000; Sapolsky and Steinberg, 1999; Suhr and Gage, 1999) . Although several viral vectors such as those derived from herpes simplex viruses (HSV) or adenoassociated virus (AAV) show some preferential infection of neurons when directly injected into the brain, an efficient and safe gene delivery system entirely specific for neuronal cells has not been developed (Berry et al., 2001; During and Leone, 1995; Jacobs et al., 1999) .
To generate vectors specific for one cell type, experiments have been initiated in several laboratories to endow retroviral vectors with genetically modified envelope proteins (Cosset and Russell, 1996; Dornburg, 1995 Dornburg, , 1997 Dornburg and Pomerantz, 2000) , which mediate binding of the virus to a specific receptor of the target cell (Hunter and Swanstrom, 1990) . In the past decade, our laboratory has been developing cell-type-specific retroviral vectors derived from spleen necrosis virus (SNV). SNV is a member of the avian reticuloendotheliosis viruses (REV), which are not infectious in human cells (Gautier et al., 2000) . We have demonstrated that SNV-derived retroviral vector particles, which display the antigen-binding site of an antibody (single chain antibody, scA) against a human cell-surface protein made possible cell-type-specific gene delivery into human cells . The nature of the scA played an important role in the efficiency of infection and a highly efficient gene transfer into human cells could be obtained in vitro (Chu and Dornburg, 1997; Chu et al., 1994 Engelstadter et al., 2000; Jiang et al., 1998; Jiang and Dornburg, 1999) . In addition, first proof of principle experiments showed that a cell-type-specific gene delivery could also be obtained in vivo (Jiang and Dornburg, 1999) .
One of the major shortcomings of retroviral vectors derived from C-type retroviruses, such as murine leukemia virus (MLV) or REVs, is their inability to infect quiescent cells such as neurons (Bukrinsky et al., 1993; Lewis and Emerman, 1994; Schwedler et al., 1994) . To bypass this problem, we recently constructed SNV-derived vectors particles, which contain a nuclear localization sequence (NLS) in the matrix (MA) protein. We showed that such vectors, which displayed a scA specific for human hematopoietic cells, assisted infection of quiescent human T lymphocytes and macrophages in vitro (Parveen et al., 2000) .
In the present study, we demonstrate that SNV-derived vectors which display the envelope protein of rabies virus (RVs) could transfer marker gene into neuronal cells in a highly efficient manner. RVs are enveloped, nonsegmented, negative-strand RNA viruses. RVs are highly neurotropic and usually cause a fatal infection in all warm-blooded species, with virus replication primarily occurring in neu-rons. A single transmembrane envelope (G) protein is responsible for both the attachment to host cells receptor and the fusion and release of the viral core into the cytoplasm. Different RV strains differ in their preference for infecting neuronal cells. Recently, two RV variants, termed CVS-N2c and CVS-B2c, that differ genotypically and phenotypically, were isolated from the mouse-adapted rabies virus strain CVS-24 (Dietzschold et al., 2000; Morimoto et al., 1998 Morimoto et al., , 1999 Morimoto et al., , 2001 . The RV strain CVS-N2c is highly neuroinvasive and neurotropic, whereas the RV strain CVS-B2c is less neuroinvasive. Here we show that SNV-derived vectors pseudotyped with the envelope of the RV strain CVS-N2c facilitated cell-type-specific gene delivery into neuronal cells in vitro and in vivo.
Results

Retroviral vectors
Previously, it has been reported that SNV virus particles containing the gag proteins of the closely related reticuloendotheliosis virus strain A (REV-A) infect some mammalian cells more efficiently than virus particles containing the gag of SNV (Casella and Panganiban, 1993) . Thus, we constructed a series of new gag-pol gene expression vectors containing gag of REV-A and pol of SNV (e.g., plasmid pZP33, Fig. 1 ). We found that vectors containing REV-A gag proteins infected human 293T cells approximately 10 times more efficiently than vectors containing gag of SNV Fig. 1 . Schematic of plasmid constructs. Plasmid DNA constructs to generate retroviral packaging cells. pZP33 is a plasmid that expresses reticuloendotheliosis virus gag-pol proteins from the cytomegalovirus (CMV) promoter followed by the adenovirus tripartite leader sequence (AVtl) for enhanced gene expression . Gag proteins have been derived from the reticuloendotheliosis virus strain A (REV-A) and the pol gene is from SNV. To enable infection of quiescent cells, a nuclear translocalization sequence (NLS) has been introduced into MA of Gag, as described recently (Parveen et al., 2000) . PRD134 expressed the SNV wild-type envelope protein from the murine leukemia virus (MLV) U3 promoter. Plasmids pB2C and pN2C express envelope proteins of the rabies virus strains B2C or N2C, respectively. pZP36 is an SNV-derived retroviral vector expressing bacterial ␤-galactosidase gene. The SNV U3 promoters in both LTRs have been replaced with the promoter of CMV.
(A. Krupetsky and R. Dornburg, unpublished data) . In addition, we introduced an NLS sequence into the REV-A, matrix protein similar to that of the SNV MA, as described recently (Parveen et al., 2000) (Fig. 1 ).
It has been reported that the SNV long terminal repeat (LTR) promoter is weak in rodent cells (Embretson and Temin, 1986) . Therefore, to perform in vivo studies in mice, we constructed a novel retroviral vector, which contains the cytomegalovirus (CMV) promoter in both LTRs, replacing the SNV LTR promoter (plasmid pZP36, Fig. 1 ). Using pZP36, we were able to transduce the bacterial LacZ gene into human 293T or dog D17 cells with titers similar to that of vectors containing two SNV wild-type LTRs (data not shown).
In vitro studies
To obtain an insight into whether vector particles pseudotyped with the envelope proteins of rabies viruses are infectious in human cells, transient transfection/infection experiments were performed. To generate retroviral vector particles, 293T cells were transfected with a plasmid expressing the reticuloendotheliosis virus core proteins (pZP33), an SNV-derived plasmid expressing bacterial ␤-galactosidase gene (pZP36), and plasmids expressing the VSV G protein, the rabies virus envelope proteins (strain B2c or N2c, Fig. 1 ), or the SNV envelope protein. Fortyeight hours after the transfection, viral supernatant was harvested from transfected cell cultures. This supernatant was used to transduce various dividing/growth-arrested target cells for the determination of infection, as described previously (Mukhtar et al., 2000) .
In agreement with our previous results (Chu et al., 1994; Gautier et al., 2000) , it was observed that retroviral particles containing the envelope protein of wild-type (wt) SNV did not infect human, mouse, or hamster cells (293T, NA, or BSR cells, respectively). However, they infected dog D17 cells (Table 1) . Retroviral particles pseudotyped with the envelope protein of Vesicular stomatitis virus (VSV) infected all cell lines tested with vector titers up to 10 4 colony forming units per milliliter (CFU/ml) of tissue culture supernatant medium (Table 1) . Particles pseudotyped with the rabies virus envelope protein of the virus strain B2C infected human, hamster, and mouse cells with titers similar to that obtained with particles pseudotyped with the envelope protein of VSV (Indiana strain, Table 1 ). However, some human cell lines such as 22-RvI and PC-3 cells (prostate cancer cells) could not be infected (Table 1) . Retroviral vector particles pseudotyped with the envelope of the rabies virus strain N2C only infected dividing and growth-arrested mouse neuroblastoma cells (NA cells, Figs. 2A and B ), but no infection of the human or nonhuman cell lines could be detected (Table 1) . Similarly, N2C pseudotyped vectors did not infect human SupT1 T cells, stromal, or Phillip skin cells (data not shown). These in vitro experiments indicate that retroviral vector particles can be pseudotyped with the envelope proteins of rabies virus. Pseudotyping with the envelope protein of the neurotropic virus N2c led to the specific infection of mouse neuroblastoma cells in vitro.
Infectivity of N2C pseudotyped vectors was further tested in differentiated mouse neurons prepared from NA cells, as described previously (Palmer et al., 2001) . These cells were also infected with similar efficiency compared to growth-arrested NA cells (Fig. 2C ). To verify that the NA cells had indeed differentiated into neurons, these cells were stained with X-gal as well as with neuronal marker antibody (NeuN) specific for a protein only expressed in mature neuronal cells (Mullen et al., 1992) . Approximately 99% of all cells expressed this marker protein specific for mature neurons (Fig. 2D ).
To further test infectivity of REV vectors pseudotyped with rabies virus envelope proteins, infectivity studies were performed with differentiated human neurons derived from Ntera-2 clonal human embryonal teratocarcinoma (NT2) cells (Lee and Andrews, 1986) . Differentiated human neurons were obtained from NT2 precursor cell line as described previously (Mukhtar et al., 2000) , cultivated in two-well chamber slides (Nalgene, Nunc) and infected with 200 l of viral stocks. Human neurons were also infected with vectors containing VSV-G or rabies virus envelope Note. 293T cells were transfected with the REV-A/SNV gag-pol expression vector pZP33, the retroviral vector pZP36 (Fig. 1) , and plasmids expressing the envelope indicated in the left column. After 48 h, supernatant containing virus was harvested for the transduction of various dividing and growth-arrested cells. VSV-G, envelope of vesicular stomatitis virus; B2C and N2C envelopes of rabies virus strains B2C and N2C, respectively, were used. NA: rat neuroblastoma cells; nd: not done.
proteins. Up to 90% of the neuronal cells were infected and no difference in the efficiency of infection was observed between vector viruses displaying either RV or VSV envelope proteins (data not shown). Fig. 2E shows human neurons infected with vectors displaying the N2C envelope proteins. Infection of human neuronal cells with REV-derived vectors was found to be more efficient than that with vectors derived from human immunodeficiency virus type I (HIV-1) pseudotyped with the VSV-G protein (data not shown). This finding is supported by previous reports that HIV-1-derived vectors pseudotyped with the VSV envelope infect neurons at relatively low levels (Bukrinsky et al., 1993; Lewis and Emerman, 1994; Naldini et al., 1996a Naldini et al., , 1996b von Schwedler et al., 1994) .
In another set of experiments, infectivity studies were performed in primary mouse neurons. We isolated the brain from 0-day-old mice, cut the hippocampal and dentate gyrus areas into small pieces, and isolated neurons in tissue cultures as described (Roy et al., 2000a (Roy et al., , 2000b . Infectivity experiments were performed with vectors displaying the N2C envelope protein, when the cells were clearly differentiated into mature neurons (approximately 6 weeks). We found that mouse primary neuronal cells could also be infected in vitro (Fig. 2F) . After X-gal staining for the presence of the bacterial LacZ protein, the plates were stained with the NeuN antibody (Mullen et al., 1992) . These experiments confirmed that the infected cells ( Fig. 2F) were indeed mature neuronal cells (Fig. 2G) .
In vivo studies
To test the infectivity of retroviral particles pseudotyped with rabies virus envelope proteins in vivo, we injected viral vector supernatant into the brain of newborn mice (strain C57 BL/6 J-twi). For microinjection, retroviral vector particles were concentrated by ultracentrifugation (Burns et al., 1993) . Two microliters of concentrated virus solution (approximately 2 ϫ 10 5 infectious virus particles) were injected into the right lateral lobe or into the cerebellum. Two months after the injection, the mice were sacrificed and the whole brain was fixed, paraffin embedded, and sliced before being subjected to immunostaining for LacZ expression. We found that many of the cells around the injection sites expressed the ␤-galactosidase gene (Fig. 3B ) and no difference in the efficiency of infection was observed between viruses expressing rabies virus or VSV envelope proteins (Table 2) . Control mice were infected with tissue culture medium harvested from cells expressing a retroviral vector transducing the LacZ gene and the envelope protein of SNV, without gag-pol proteins ( Fig. 3BЈ and Table 2 ) These data indicate that SNV vector particles displaying the RV or the VSV envelope are infectious in vivo.
To further investigate cell-type-specificity of vectors pseudotyped with the CVS-N2C envelope, 0.5-m-thin histological sections of the infected mice brain were prepared (Naldini et al., 1996a (Naldini et al., , 1996b and stained first with an antibody against the bacterial ␤-galactosidase and then with NeuN (double staining). NeuN is a nuclei-specific antibody and is not detectable in neurites (Mullen et al., 1992) . In the case of mice brains infected with vectors displaying the N2c envelope, the expression of the LacZ gene was confined to cells showing positive staining with the antibody against neuronal cells. For example, hippocampal, cortical, as well as some neurons in cerebellum region but none of the Fig. 2 . In vitro infection of neuronal cells with N2C-pseudotyped envelope. All cells shown were infected with REV-derived vectors displaying the rabies virus strain N2C envelope protein. The retroviral vectors transduced the bacterial LacZ gene. Cells were stained for ␤-galactosidase expression. Blue cells indicate successful gene transfer. (A) Infectivity in dividing mouse NA cells (infected with a 1:10 vector dilution); (B) infectivity in growth-arrested NA cells (infected with a 1:10 vector dilution); (C) infectivity in mouse mature neurons derived from NA cells; (D) the same cells shown in C stained with an antibody specific for mature neurons (NeuN); (E) infectivity in human neuronal cells derived from NT2 cells; (F) infectivity in mouse neurons derived from primary mouse brain cells; (G) cells shown in F were stained with an antibody specific for neuronal cells. Fig. 3 . Mouse brains infected in vivo. Vector particles transducing the bacterial LacZ gene and pseudotyped with the envelope protein of the rabies virus strain N2C were injected into the cerebellum of newborn C57 BL/6 J-twi mice at day 0. Two months after the injection, the mice were sacrificed and the brains were removed, fixed with 4% paraformadehyde, paraffin embedded, and processed for respective antibody staining. A and AЈ are the site of viral injection in to the mice brain (arrows). A flux of macrophages is observable (arrow) at the site with phagocytic activity. B represents the same area with dual staining using anti-LacZ and anti-NeuN antibodies. (negative control). BЈ is a negative control micrograph for cerebellum with dual staining against LacZ and neurons. C and CЈ are cerebellum of mice infected with SNV vectors displaying rabies virus N2C envelope proteins with NeuN and LacZ staining.
surrounding nonneuronal cells expressed the bacterial ␤-galactosidase protein (Fig. 3C; Figs. 4c, d, and f, respectively) . In the case of brains infected with vectors displaying the CVS-B2c or VSV-G envelope, we found that ␤-galactosidase was expressed mainly in neurons showing preferential neuronal infection with such vectors (Figs. 4h and i). However, in contrast to infectivity studies with N2c pseudotyped vectors, we found regions in the cortex in which many different cell types appeared to be infected with B2C pseudotyped vectors (Fig. 4j) . In another set of experiments, thin sections of the brain were stained with an antibody specific for astrocytes. We found that some astrocytes were infected with vectors displaying the B2C envelope, but not with vectors displaying the N2C envelope (data not shown). These results coincide with results of our in vitro studies, i.e., vectors pseudotyped with the B2c envelope infected not only neurons, but also other cell types in vivo (Fig. 4j) . Also results obtained with VSV-G (Fig. 4h ) pseudotyped vectors were similar to that of B2C pseudotyped vectors. Vectors displaying N2C envelope deliver gene specifically into neurons compared with all other envelope pseudotypes described in this study.
Discussion
Many degenerative diseases of the brain are caused by single defective genes and, in these cases, lack of particular protein expression manifest disease (Kalaria, 2001) . Thus, gene transfer into human neurons may become a powerful tool to improve the health and well being of affected individuals (Costantini et al., 2000; Kalaria, 2001; Suhr and Gage, 1999) . However, the lack of an efficient and safe gene delivery system specific for neurons constitutes one of the major obstacles toward this goal.
In this study, we performed infectivity assays in neuronal cells with REV-derived vectors pseudotyped with RV envelope proteins. SNV-derived vectors displaying the RV envelope protein CVS-B2c, N2c infected human cells in vitro with efficiency comparable to that of vectors pseudotyped with the VSV-G protein. Vector virus titers with virus stocks obtained in transient transfection/infection experiments were comparable to vector virus titers of SNV vectors displaying the SNV wild-type envelope in D17 cells (Dornburg, 1995) . Moreover, our data indicate that SNV vectors pseudotyped with the envelope of highly neurotropic RV strain, such as CVS-N2c, selectively infected mouse and human neuronal cells in vitro.
Previously, we have reported that introduction of a NLS sequence into the MA protein of SNV enabled the infection of quiescent human T cells and macrophages in vitro (Parveen et al., 2000) . Here, we describe that similar vectors containing the complete gag region of REV-A and a NLS sequence in MA, as described previously (Parveen et al., 2000) , also made possible infection of growth-arrested mouse neuroblastoma cells as well as differentiated mouse and human neurons in in vitro. However, no conclusions can be drawn at this time on whether these vectors also infect quiescent neurons in vivo, because the brain of newborn mice is still not fully differentiated and the brain cells also undergo some cell division. However, the present data clearly indicate that vectors displaying the RV strain N2C envelope infected only neurons in vivo, which was the primary objective of this study.
In summary, we have demonstrated that reticuloendotheliosis virus derived vectors pseudotyped with RV envelope proteins from highly neuroinvasive RV strains may have great potential for targeted human gene therapy of neurological disorders. Such vectors not only facilitated efficient infection of neuronal cells in vitro, but also sustained longterm gene expression in vivo. However, to fully evaluate the clinical therapeutic potential of this vector system, high-titer packaging cell lines need to be constructed which express various therapeutic genes. Such vectors could then be directly applied in animal model systems for various degenerative diseases and/or genetic defects of the brain.
Materials and methods
Plasmid constructs
Plasmid DNAs were constructed following standard DNA cloning procedures. Retroviral core protein coding sequences Note. Newborn mice were infected with SNV-derived retroviral vectors displaying various envelope proteins and transduced with the ␤-galactosidase gene. Eight weeks after the injection of virus, the mice were sacrificed and the brains were analyzed for the expression of the marker gene. VSV-G, envelope protein of vesicular stomatitis virus; B2C, envelope protein of the rabies virus strain B2C; N2C: envelope protein of the rabies virus strain N2C. Tissue culture supernatant form nontransfected viral producing cells (293T) was used as a control. Fig. 4 . Immunostaining of thin sections of mouse brains. Newborn mice were infected with REV-derived vectors pseudotyped with various envelope proteins. Two months after infection, the brains were isolated and analyzed for cell-type-specific expression of the LacZ marker gene by double staining of thin sections with an antibody specific for the expression of LacZ protein and neuron-specific antibody (NeuN). The NeuN antibody recognizes a protein which is located or envelope genes were cloned into the universal eukaryotic gene expression vectors pRD114 or pWS4 . Plasmid pZP33 is similar to pRD136, which expresses SNV gag-pol proteins . However, pZP33 contains the gag coding sequences of the REV-A. Using site-directed mutagenesis, a nuclear translocalization signal sequence has been introduced into MA similar to plasmid construct pRD136-m7 (Parveen et al., 2000) . Gag-pol proteins are expressed from the CMV immediate early promoter. Plasmid pMDG expresses the VSV envelope protein (Naldini et al., 1996a (Naldini et al., , 1996b , and plasmid pRD134 expresses the SNV envelope protein . Plasmids pN2C and pB2C were constructed using polymerase chain reaction (PCR) to amplify the envelope coding sequences from cloned rabies virus cDNAs R-N2c or R-B2c, respectively (Morimoto et al., 1998 (Morimoto et al., , 2001 . The primers used were: 5Ј-CCTCTAGAAGATGGTTCCTCAG-GCTC-3Ј and 5Ј-TATAGGGCCCAAGCTTTCACAGTCT-GATCTCACCTC-3Ј. The PCR products were digested with XbaI and HindIII and the resulting DNA fragments were cloned into the universal gene expression vector pWS4 digested with XbaI and HindIII (Fig. 1) .
The cell lines 293T (human embryonic kidney cells), D17 (dog osteosarcoma cells), BSR (Chinese hamster kidney), and primary cells obtained from mouse brains were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Gibco-BRL, USA) in the presence of 1% penicillin and 1% streptomycin. NA (rat neuroblastoma cells) cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum in the presence of 1% penicillin and 1% streptomycin. NT2 cells (Ntera2/D1 derived from a human teratocarcinoma) were obtained from Stratagene (La Jolla, CA). NT2 and NA cells were differentiated into mature neurons by maintaining them in DMEM/F12 medium in the presence of mitotic inhibitors and retinoic acid and by plating them on poly-D-lysine and laminin-coated plates following the protocol suggested by the supplier (Stratagene). Various cell types were growth-arrested using mitomycin as described previously (Bukrinsky et al., 1993; Lewis and Emerman, 1994; Miyake et al., 1998; von Schwedler et al., 1994) .
Generation of retroviral vector particles displaying rabies virus envelope proteins. To generate retroviral particles that display the envelope protein of a rabies virus, plasmids expressing the retroviral core proteins (pZP33), the retroviral vector (pZP36), and plasmids expressing an envelope protein (e.g., pN2C or pB2C) were cotransfected into human 293T cells. The transfections were performed using Promega (Madison, WI) transfection kit according to manufacturer-suggested protocols. Forty-eight hours after the transfection, the supernatants were filtered through 0.45-m Nalgene filters (Rochester, NY). The viral vector supernatants were used to transduce a variety of target cells. After 48 h, the infected target cells were stained for ␤-galactosidase expression as described previously (Mikawa et al., 1991; Parveen et al., 2000) . Concentrated virus stocks were prepared as previously described (Burns et al., 1993) . Briefly, viral particles were harvested from transfected 293T cells and passed through a 0.45 m filter (Nalgene). Thirty milliliters of the virus solution was concentrated by ultracentrifugation in a Sorvall PC centrifuge at 25,000 rpm for 2 h. The viral pellet was resuspended in 100 l DMEM medium. The titer of concentrated virus particles was determined by infecting the 293T cells before injecting into the mouse brain.
Viral injection into mouse brain
Zero-day-old mice (strain C57 BL/6J-wt/t) were positioned on a mini-light box with heads fixed and 2 l of viral particles (2 ϫ 10 5 CFU) was injected into the right and left hemisphere or into the cerebellum, targeting the hippocampal, cortical, or cerebellum, using a Hamilton syringe with a 33-gauge needle (Hamilton, Reno, NV) at the rate of 0.2 l/min. The needle was left in the tissue for an extra 30 s to completely remove the virus (Antel et al., 2000) .
Histology
Eight weeks after the viral injections the animals were anesthetized and sacrificed. The complete brains were removed and washed in ice-cooled 1 ϫ PBS and then soaked in 4% paraformaldehyde for 4 h followed by X-gal staining or were paraffin embedded for histology and immunohistostaining as described previously (Dhingra et al., 2000) .
Immunostaining
Paraffin embedded brain tissues were sliced into 5-m sections, deparaffinized in xylene, and then rehydrated in cold 1 ϫ PBS before the standard H&E staining or immunohistology, as described previously (Eberhardt et al., 2000; Mullen et al., 1992; Naldini et al., 1996a Naldini et al., , 1996b . For ␤-galactosidase detection, the tissues were incubated with a mouse anti-␤-galactosidase antibody (IgM, purchased from Sigma, St. Louis, MO) followed by incubation with goat anti-mouse IgM antibody termed Alexa fluor 546 (Molecular Probes, Eugene, OR). As a negative control, tissue sections were incubated with secondary antibody alone, under similar conditions. Dual staining was performed for the localization of LacZ gene expression and neurons with around the nucleus. Thus, the neurites are not visible using this staining technique. a is standard H&E staining showing intact structural morphology. Panels b-f are the hippocampal and cortical neuronal areas of the mice infected with N2C pseudotyped vectors. Panels g, h, i, and j are thin sections of the cortex region of mice infected with VSV-G and B2C-pseudotyped vectors, respectively. the help of anti-LacZ antibody and mature neuronal marker antibody, NeuN (IgG) (Chemicon International Temecula, CA). Respective secondary antibodies, goat anti-mouse (IgM, Alexa Fluor 546) and rabbit anti-mouse IgG (Alexa Fluor 647), were used to detect the expression of each protein individually in each cell.
Isolation of neurons from mouse brain cells
Zero-day-old mice brain were isolated as described above (under Histology) and the hippocampal and cerebellum tissues were separated from brain and cut into small pieces, rinsed twice with ice-cold phosphate-buffered saline (PBS), and incubated at 37°C for 15 min in PBS containing 0.025% trypsin, 10 g/ml DNase and papain, and 3 mM MgCl 2 . After adjusting the solution to 15% FBS, the cell suspension was centrifuged for 10 min at 200 g and resuspended in DMEM/F12 with 20 nM FGF-2 (Sigma) and 10% nonactive FBS (Parveen et al., 2000) . After 4 days in culture, the cells were transferred to poly-D-lysine and laminincoated plates and cultivated as described earlier (under cell lines and culture), until they matured into neurons.
